期刊文献+

94例唑来膦酸注射液不良反应分析 被引量:4

Analysis on 94 cases of adverse drug reactions of Zoledronic Acid Injection
在线阅读 下载PDF
导出
摘要 目的通过收集唑来膦酸注射液在临床上常见的不良反应,并对不良反应的特点和规律进行分析,提出预防不良反应发生的有效措施,保证患者用药安全。方法对2011年1月1日~2016年9月30日淄博市药品不良反应中心收集到的94例唑来膦酸注射液不良反应,按照人群年龄与性别、累计系统-器官、发生时间、新的或严重的不良反应等方面进行分析。结果 94例不良反应女性所占构成比明显高于男性,46岁以上患者不良反应发生率最高;临床累及器官或系统主要为包括全身性、神经系统、消化系统、皮肤及其附件系统、泌尿系统、呼吸系统损害等;不良反应发生时间多为在用药后24 h内,属速发型不良反应。结论生产企业应加强女性患者和中老年患者用药方面的研究工作,临床上应密切监护,规范用药,保证患者用药安全。 Objective To put forward the effective measures for preventing the occurrence of adverse reactions and ensure the safety of the patients by collecting the common adverse reactions of Zoledronic Acid Injection in clinic,and analyzing the characteristics and laws of adverse reactions.Methods According to the age and sex of the population,the cumulative system-organ,the time of occurrence,the new or the adverse effect of zoledronic acid injection on 94 cases of zoledronic acid injection adverse reactions collected by Zibo Center for ADR Monitoring from January 1 st 2011 to September 30 th2016.Results The incidence of adverse events proportion of female was more higher than male,The incidence of adverse reactions was highest in patients over 46 years of age,involving mainly systemic organ or system damage,including nervous system,digestive system,skin and the appendages,urinary system and respiratory system. Adverse reactions occurred less than 24 hours after treatment within the fast hair type of adverse reactions. Conclusion Pharmaceutical manufacturers should strengthen the study on the use of drugs in women patients and middle-aged and elderly patients.It should be closely monitored and regulate medication in clinical to ensure the medication safety of patients.
作者 张歆 周文琦 ZHANG Xin;ZHOU Wenqi(ZiBo Center for ADR Monitoring,Zibo 255020,China)
出处 《药学研究》 CAS 2018年第8期493-495,共3页 Journal of Pharmaceutical Research
关键词 唑来膦酸注射液 不良反应 含氮双膦酸盐类药物 Zoledronic Acid Injection Adverse drug reaction Nitrogen-containing bisphosphonates drug
作者简介 张歆,男,主管药师,研究方向:药品不良反应监测,E-mail:2804075527@qq.com
  • 相关文献

参考文献6

二级参考文献40

  • 1戴月华,张海军.唑来膦酸加速肾功能损害引起死亡1例[J].中国药师,2006,9(9):814-814. 被引量:7
  • 2彭六保,崔巍.唑来膦酸的临床应用研究进展[J].中国新药与临床杂志,2007,26(3):237-240. 被引量:36
  • 3苏钟毅,尹芸生,李栋,胡宏亮,刘巍,郝东升.胰岛素样生长因子-Ⅰ促骨质疏松骨折愈合的实验研究[J].中国药物与临床,2007,7(3):182-185. 被引量:14
  • 4曹永红.唑来膦酸钠注射剂致低钙血症2例[J].中国药师,2007,10(4):372-372. 被引量:8
  • 5Russell RG.Bisphosphonates:from bench to bedside[J].Ann NY Acad Sci,2006,1068:367-401.
  • 6Rogers MJ,Gordon S,Benford HI,et al.Cellular and molecular mech-anisms of action of bi sphosphonates[J].Cancer,2000,88(Suppl 12):2961-2978.
  • 7Schmid C,Guler HP,Rowe D,et al.Insulin-like growth factor 1 regulates type 1 procollagen messenger ribonucleic acid steady state levels in bone of rats[J].Endocrinology,1989,125(3):1575-1580.
  • 8Miyakoshi N,0in X,Kasukawa Y,et al.Systemic administration of insulinlike growth factor (1GF-1)-binding protein-4 (IGFBP-4) increases bone formation parameters in mice by increasing IGF bioavailability via an IGFBP-4 protease-dependent mechanism[J].Endocrinology,2001,142(6):2641.
  • 9Hock JM,Centrells M,Canalis E,et al.Insulin-like growth factor 1 has independent effects on bone matrix formation and cell replaction[J].Endocrinology,1988,122(1):254.
  • 10Pan B,To LB,Farrugia AN,et al.The nitrogen-containing bisphosphonate,Zoledronic acid,increases mineralisation of human bone-derived cells in vitro[J].Bone,2004,34(1):112-123.

共引文献25

同被引文献36

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部